Korean iPSC Derived Cell Provider with New Discovery and Development | NEXELby Professional Writer Professional Writer
NEXEL Co., Ltd. aspires to be a world-class biotech company. Its goal is to create innovative new therapies to help patients while also providing tools for researchers to help them with their projects. As a result, they will create value for investors, fellow researchers, and the world in order to make it a better place. As the first Korean company to licenceiPS technology, NEXEL has established a new paradigm in the field of in vitro toxicity through the successful commercialization of iPS derived cells that mimic actual human functionality.
In addition, they are putting their expertise to work in the discovery and development of new drug candidates based on proteins and peptides derived from stem cell technology.Their
team is made up of talented people who share passion for innovation and high scientific standards. They are supported by invaluable collaborators from the academic and clinical communities.
Korean iPSC Derived Cell Provider
NEXEL uses optimised proprietary protocols to produce high-quality human cardiomyocytes from human induced pluripotent stem (iPS) cells. Cardiosight-S is a highly pure and electrophysiologically active cell population that is suitable for all types of cardiomyocyte experiments. Its top priority is to ensure that researchers receive a reliable product while also accelerating the various projects they are working on. Furthermore, its human iPSC-derived cardiomyocytes have been validated across multiple platforms, and the quality control process has been optimised to test the precise settings in which customers use its product.
The cells have been thoroughly tested on both the nanion cardioexcyte96 and the axion maestro MEA, making them the best choice for your MEA assay. Its certificate of analysis (CoA) details the exact results obtained, and the technical support team will collaborate with you to replicate the experience in your lab.
If you are looking for iPSC technology derived cell provider, you can find it at NEXEL.
Click here to contact NEXEL.
View more: Korean iPSC Derived Cell Provider
Created on Feb 27th 2023 00:13. Viewed 32 times.